Disclaimer: The analyst who wrote this piece owns shares of Strategy (MSTR).Strategy (MSTR) expects its convertible preferred ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

Hotel101 Global—a unit of DoubleDragon, which is jointly owned by Philippine fast food giant Jollibee founder Tony Tan ...

K SEC filing received on January 31, 2025, that the company has been notified by The Nasdaq Stock Market, LLC about its failure to meet the minimum bid requirement for continued listing on the Nasdaq ...

DoubleDragon Corp., the property venture of tycoons Edgar Sia II and Tony Tan Caktiong, has moved a step closer toward ...

We recently published a list of 10 Best Dividend Stocks Yielding at Least 7% According to Analysts. In this article, we are ...

The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Zentalis, or following a bona fide period of non-employment, as an ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement ...

DoubleDragon Corp., the property venture of tycoons Edgar “Injap” Sia and Tony Tan Caktiong, has moved a step closer toward listing Singapore-headquartered Hotel101 Global Pte. Ltd. on the Nasdaq ...